LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals
Open Access
- 15 February 2016
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 14 (2), 155-164
- https://doi.org/10.2174/1570159x14666151204122017
Abstract
Neuroinflammation is an important feature in the pathogenesis and progression of neurodegenerative diseases such as Alzheimer´s disease (AD), Parkinson´s disease (PD), frontotemporal dementia and amyotrophic lateral sclerosis. Based on current knowledge in the field, suggesting that targeting peripheral inflammation could be a promising additional treatment/prevention approach for neurodegenerative diseases, drugs and natural products with anti-inflammatory properties have been evaluated in animal models of neuroinflammation and neurodegeneration. In this review, we provide an extensive analysis of one of the most important and widely-used animal models of peripherally induced neuroinflammation and neurodegeneration - lipopolysaccharide (LPS)-treated mice, and address the data reproducibility in published research. We also summarize briefly basic features of various natural products, nutraceuticals, with known anti-inflammatory effects and present an overview of data on their therapeutic potential for reducing neuroinflammation in LPS-treated mice.Keywords
This publication has 108 references indexed in Scilit:
- Oenothein B Suppresses Lipopolysaccharide (LPS)-Induced Inflammation in the Mouse BrainInternational Journal of Molecular Sciences, 2013
- A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) MiceNeurotherapeutics, 2012
- Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer's DiseaseThe American Journal of Pathology, 2011
- Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysisBrain, Behavior, and Immunity, 2011
- Inflammation Induced by Infection Potentiates Tau Pathological Features in Transgenic MiceThe American Journal of Pathology, 2011
- Signaling Pathways in Reactive Astrocytes, a Genetic PerspectiveMolecular Neurobiology, 2011
- APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesisBrain Structure and Function, 2009
- Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokinesBrain, Behavior, and Immunity, 2008
- Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune systemBrain, Behavior, and Immunity, 2007
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007